MedPath
NMPA Approval

吡罗昔康

H20160271

May 10, 2016

H20110325

Drug Information

吡罗昔康

原料药

化学药品

May 10, 2016

May 9, 2021

Company Information

Applicant Company

235 East 42nd Street,New York,NY 10017,United States

Manufacturing Company

Ringaskiddy,Co. Cork

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吡罗昔康 - NMPA 批准文号 | MedPath